# Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

> **NCT00959725** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 10 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Infliximab (intravitreal, 2.0mg/0.05ml)

## Key facts

- **NCT ID:** NCT00959725
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959725, "Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00959725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*